The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Final analysis of intergroup randomized phase III study of androgen deprivation therapy (ADT) plus radiation therapy (RT) in locally advanced prostate cancer (CaP) (NCIC-CTG, SWOG, MRC-UK, INT: T94-0110).
Malcolm David Mason
No relevant relationships to disclose
Wendy Parulekar
No relevant relationships to disclose
Matthew Robert Sydes
No relevant relationships to disclose
Mahesh Parmar
No relevant relationships to disclose
John Anderson
No relevant relationships to disclose
Jim Barber
No relevant relationships to disclose
Michael Donald Brundage
No relevant relationships to disclose
Richard Cowan
No relevant relationships to disclose
Mary K. Gospodarowicz
No relevant relationships to disclose
Charles Hayter
No relevant relationships to disclose
John Hetherington
No relevant relationships to disclose
Andrea Clare Hiltz
No relevant relationships to disclose
Peter Kirkbride
No relevant relationships to disclose
Edward Kostashuk
No relevant relationships to disclose
Karen Sanders
No relevant relationships to disclose
Jinka Sathya
No relevant relationships to disclose
Gregory P. Swanson
No relevant relationships to disclose
Bingshu E Chen
No relevant relationships to disclose
Padraig Richard Warde
No relevant relationships to disclose